Re: Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-sparing Trimodality Therapy for Muscle-invasive Bladder Cancer

Eur Urol. 2019 Jun;75(6):1034-1035. doi: 10.1016/j.eururo.2019.02.022. Epub 2019 Mar 2.

Authors

Vikram M Narayan¹, Amy H Lim¹, Colin P N Dinney²

Affiliations

¹ University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: cdinney@mdanderson.org.

PMID: 30833138
DOI: 10.1016/j.eururo.2019.02.022

No abstract available

Publication types

Comment

MeSH terms

Cystectomy
Humans
Organ Sparing Treatments
Urinary Bladder Neoplasms*